416 related articles for article (PubMed ID: 31964738)
1. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
[TBL] [Abstract][Full Text] [Related]
2. Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein.
Sandrin V; Cosset FL
J Biol Chem; 2006 Jan; 281(1):528-42. PubMed ID: 16195228
[TBL] [Abstract][Full Text] [Related]
3. IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.
Verma S; Chen YC; Marin M; Gillespie SE; Melikyan GB
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140631
[TBL] [Abstract][Full Text] [Related]
4. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
5. Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.
Gregory DA; Lyddon TD; Johnson MC
J Virol; 2013 Feb; 87(3):1518-27. PubMed ID: 23152533
[TBL] [Abstract][Full Text] [Related]
6. O-sulfate groups of heparin are critical for inhibition of ecotropic murine leukemia virus infection by heparin.
Seki Y; Mizukura M; Ichimiya T; Suda Y; Nishihara S; Masuda M; Takase-Yoden S
Virology; 2012 Mar; 424(1):56-66. PubMed ID: 22226323
[TBL] [Abstract][Full Text] [Related]
7. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
Yu J; Li M; Wilkins J; Ding S; Swartz TH; Esposito AM; Zheng YM; Freed EO; Liang C; Chen BK; Liu SL
Cell Rep; 2015 Oct; 13(1):145-156. PubMed ID: 26387945
[TBL] [Abstract][Full Text] [Related]
8. The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex.
Usami Y; Popov S; Göttlinger HG
J Virol; 2014 Mar; 88(6):3443-54. PubMed ID: 24403584
[TBL] [Abstract][Full Text] [Related]
9. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
10. Duck Interferon-Inducible Transmembrane Protein 3 Mediates Restriction of Influenza Viruses.
Blyth GA; Chan WF; Webster RG; Magor KE
J Virol; 2016 Jan; 90(1):103-16. PubMed ID: 26468537
[TBL] [Abstract][Full Text] [Related]
11. The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.
Narayana SK; Helbig KJ; McCartney EM; Eyre NS; Bull RA; Eltahla A; Lloyd AR; Beard MR
J Biol Chem; 2015 Oct; 290(43):25946-59. PubMed ID: 26354436
[TBL] [Abstract][Full Text] [Related]
12. Dysfunction of bovine endogenous retrovirus K2 envelope glycoprotein is related to unsuccessful intracellular trafficking.
Nakaya Y; Miyazawa T
J Virol; 2014 Jun; 88(12):6896-905. PubMed ID: 24696495
[TBL] [Abstract][Full Text] [Related]
13. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein.
Sakuma T; De Ravin SS; Tonne JM; Thatava T; Ohmine S; Takeuchi Y; Malech HL; Ikeda Y
Hum Gene Ther; 2010 Dec; 21(12):1665-73. PubMed ID: 20507233
[TBL] [Abstract][Full Text] [Related]
14. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Compton AA; Bruel T; Porrot F; Mallet A; Sachse M; Euvrard M; Liang C; Casartelli N; Schwartz O
Cell Host Microbe; 2014 Dec; 16(6):736-47. PubMed ID: 25464829
[TBL] [Abstract][Full Text] [Related]
15. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.
Suddala KC; Lee CC; Meraner P; Marin M; Markosyan RM; Desai TM; Cohen FS; Brass AL; Melikyan GB
PLoS Pathog; 2019 Jan; 15(1):e1007532. PubMed ID: 30640957
[TBL] [Abstract][Full Text] [Related]
16. Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells.
Guibinga GH; Miyanohara A; Esko JD; Friedmann T
Mol Ther; 2002 May; 5(5 Pt 1):538-46. PubMed ID: 11991744
[TBL] [Abstract][Full Text] [Related]
17. Minimal exclusion of plasma membrane proteins during retroviral envelope formation.
Hammarstedt M; Wallengren K; Pedersen KW; Roos N; Garoff H
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7527-32. PubMed ID: 10852949
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
20. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses.
Schlecht-Louf G; Renard M; Mangeney M; Letzelter C; Richaud A; Ducos B; Bouallaga I; Heidmann T
Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3782-7. PubMed ID: 20142478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
